Navigation Links
Xarelto Lawsuits Filed Contend Wrongful Death and Internal Hemorrhaging Due to Blood Thinner
Date:7/20/2014

Columbus, OH (PRWEB) July 20, 2014

The attorneys at Wright & Schulte LLC have learned through Reuters that almost 10 Xarelto lawsuits have been filed in the United States against Germany-based Bayer AG over its blood-thinning medication. Court records indicate that one of the Xarelto lawsuits was filed on behalf of a Kentucky woman who alleges developing uncontrollable internal bleeding as a result of taking the blood thinner. The Xarelto lawsuit was filed February 24 in the Pennsylvania Court of Common Pleas, Philadelphia County. (Stuntebeck v. Janssen Research & Development LLC et al, Case Number 140201754) More recently, a Florida woman filed a Xarelto wrongful death complaint in the U.S. District Court, Southern District of Florida that alleges her husband died due to uncontrollable bleeding after taking Xarelto. (Case 9:14cv80831)
[reuters.com/article/2014/06/14/us-bayer-
suit-idUSKBN0EP0HW20140614, June 14, 2014]

Xarelto, generically known as rivaroxaban, is a prescription blood thinner manufactured by Bayer and marketed in the United States by Janssen Pharmaceuticals, a division of Johnson & Johnson. The U.S. Food & Drug Administration (FDA) approved Xarelto for treatment in reducing deep vein thrombosis and pulmonary embolism in patients who had knee or hip replacement surgery and for reducing stroke and blood clot risks in patients with atrial fibrillation.
[fda.gov/NewsEvents/Newsroom/Press
Announcements/ucm326654.htm, November 2, 2012]

According to court documents, a Florida woman filed a Xarelto wrongful death complaint on June 23, 2014, in U.S. District Court, Southern District of Florida that alleges her husband was prescribed Xarelto in January 2012 to treat atrial fibrillation. According to the Xarelto lawsuit, the spouse was hospitalized on June 23, 2012, after suffering a subdural hemorrhage. He underwent a medical procedure in an attempt to stop the bleeding, but died five days later. The Florida woman’s Xarelto lawsuit contends that the defendants, Janssen Research & Development and Bayer, concealed their knowledge to consumers, the general public and the medical community that Xarelto allegedly causes life-threatening irreversible bleeds. The Xarelto lawsuit further contends the defendants did not warn or advise how to intervene and stabilize a patient should a bleed occur. (Case 9:14cv80831)

Court records further show that a Kentucky woman’s Xarelto complaint against Janssen Research & Development and Bayer Corp. alleges she was prescribed the blood thinner in July 2012 to treat atrial fibrillation. In February 2013, she suffered severe internal and gastrointestinal bleeding that required hospitalization in order for doctors to stop the bleeding. The Xarelto complaint further alleges that the defendants were negligent in introducing the drug. (Stuntebeck v. Janssen Research & Development LLC et al, Case Number 140201754) The complaint was filed a month after the Pennsylvania Supreme Court’s January 21st ruling that pharmaceutical companies in Pennsylvania can be held negligent for marketing or designing drugs that they know or should have known are to dangerous to use.
[pacourts.us/assets/opinions/Supreme/out/J-69AandB-2011mo.pdf?cb=7, January 21, 2014.]

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you or your loved one suffered serious internal bleeding or other related complications as a result of using Xarelto, contact the law firm for a free, no-obligation legal consultation. If you're looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com
Like us on Facebook
Follow us on Twitter
Join us on Google+

Read the full story at http://www.prweb.com/releases/2014/07/prweb12029984.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bernstein Liebhard LLP Launches New Xarelto Lawsuit Website for Individuals Allegedly Injured by Blood Thinner
2. Xarelto is Alleged to Cause Serious and Uncontrolled Internal Bleeding
3. Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation
4. AffordRx Now Offering Xarelto Coupon Cards
5. d'Oliveira & Associates Issues New Infographic on Xarelto Providing Current FDA and Medical Study Information
6. Federal DePuy ASR Litigation Schedules July Conference to Discuss Lawsuits over Recalled Hip Replacement
7. Nearly 780 Mirena IUD Lawsuits Now Filed in New Jersey Litigation, Bernstein Liebhard LLP Reports
8. As Testosterone Lawsuits Are Filed In The U.S., Canada Warns of Possible Cardiac Risks Associated With Testosterone Medication
9. Stryker Recall Litigation in New Jersey Now Includes More than 2,000 Lawsuits over Rejuvenate, ABG II Metal Hips, Bernstein Liebhard LLP Reports
10. Number of Testosterone Therapy Lawsuits More than Doubles in Two-Week Period, Baron and Budd Reports
11. Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... If you are thinking of a visit to San Francisco ... October is the perfect time to visit. , Business Architecture Associates is pleased to offer ... for individuals, as a 4-½ day package for individuals, and as 4-½ day corporate package ...
(Date:5/24/2017)... ... May 24, 2017 , ... Technique, technique, technique – with a ... lifting weights for strength training and exercise or simply lifting heavy objects, advises Dr. ... position is everything,” Dr. Chang says. “Improper technique in lifting anything heavy or an ...
(Date:5/23/2017)... ... 23, 2017 , ... PM360, the premier information resource for ... winners of its 3rd Annual ELITE Awards. The ELITE (Exceptional • Leaders • ... industry today. , Out of more than 500 submissions, 100 winners were selected ...
(Date:5/23/2017)... ... May 23, 2017 , ... London, May 23, 2017: ... serve earlier this month as a Guest Speaker and Contributor to a weeklong series ... and Common Purpose. , Walter Schindler and SAIL Capital ...
(Date:5/23/2017)... IN (PRWEB) , ... May 23, 2017 , ... ... the availability of video chat as a standard feature on its secure clinical ... from text to voice to video depending on the type and urgency of ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... 10, 2017 CSSi, the global leader in ... research industry, is proud to announce the launch of ... website features both enriched content and a customized layout ... the company,s already well-established position as the top global ... "After many months of hard work, we are delighted ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
(Date:5/8/2017)... FLINT, Mich. , May 8, 2017  Diplomat ... WRB Communications, Inc. ("WRB"), a health care ... . WRB specializes in relationship management ... organizations. WRB will ... of Diplomat,s commercialization support services for manufacturers, biotech firms, ...
Breaking Medicine Technology: